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and myristoylation. The dimerization site is composed of residues in EF4 and the loop region between EF3 and EF4, confirmed by mutagenesis. We present the structure of the VILIP-1 dimer and a Ca 2+ -myristoyl switch to provide structural insights into Ca 2+ -induced trafficking of nicotinic acetylcholine receptors.
Visinin-like protein 1 (VILIP-1) is a neuronal Ca 2+ sensor (NCS) protein belonging to the calmodulin superfamily of calcium sensor proteins (1) (2) (3) (4) . VILIP-1 is expressed throughout the brain with high expression levels in the rat hippocampus (5, 6) , where it may play a role in regulating synaptic plasticity relevant for learning and memory (7, 8) . VILIP-1 regulates several neuronal signaling pathways implicated in synaptic plasticity, such as cyclic nucleotide cascades (9) (10) (11) (12) and nicotinergic signaling (13) .
Moreover, VILIP-1 binds to the α−subunit of the α 4 β 2 nicotinic acetylcholine receptor (nAChR) and promotes surface expression and trafficking of α 4 β 2 nAChR in oocytes (13) and hippocampal neurons (14) . VILIP-1 has been implicated in the modulation of neuronal excitability by influencing α 4 β 2 nAChR signaling in hippocampal neurons (14) (15) (16) . VILIP-1 has also been implicated in the pathology of CNS diseases (17) , including Alzheimer's disease (18, 19) and schizophrenia. Indeed, VILIP-1 expression shows cell-specific changes in brains of schizophrenics and in animal models of the disease (16, 20, 21) . Thus, VILIP-1 appears to be an important Ca 2+ sensor for controlling neuronal excitability by modulating nicotinergic neurotransmission important for synaptic plasticity and disease processes (17, 22) .
VILIP-1 belongs to the NCS family of Ca 2+ -myristoyl switch proteins (Fig. 1) . The three-dimensional structures are known for NCS-1 (23) , recoverin (24, 25) , and neurocalcin (26) . The common structural features of NCS proteins are an approximately 200-residue chain containing four EF-hand motifs (EF1, EF2, EF3 and EF4), the sequence CPXG in the first EF-hand that eliminates its capacity to bind Ca 2+ , and an amino-terminal myristoylation consensus sequence. The binding of Ca 2+ to NCS proteins (e.g. NCS-1 (27) , recoverin (28) and neurocalcin (29) ) induces their binding to cellular membranes (29) (30) (31) . The N-terminal myristoyl group has been shown to be sequestered structurally inside Ca 2+ -free recoverin (32, 33) , whereas the binding of two Ca 2+ to recoverin leads to the extrusion of the covalently attached myristoyl group (24) . The Ca 2+ -induced exposure of the myristoyl group, termed Ca 2+ -myristoyl switch, enables recoverin and related NCS proteins to bind membranes only at high Ca 2+ . In this study, we report on the structural analysis of Ca 2+ and Mg 2+ binding to VILIP-1 to characterize the structural mechanism of the Ca 2+ -myristoyl switch and determine its dimeric structure. We show that VILIP-1 binds functionally to Mg 2+ at EF3 and binds cooperatively to Ca 2+ at EF2 and EF3. VILIP-1 sequesters its N-terminal myristoyl group inside the apo-protein core and exhibits Ca 2+ -induced extrusion of the myristoyl group like that of recoverin. However, unlike recoverin, VILIP-1 forms a dimeric structure that is independent of Mg 2+ , Ca 2+ or myristoylation. The dimerization site on VILIP-1 is comprised of non-conserved residues in EF4 and the loop region between EF3 and EF4. We propose a structural model of VILIP-1 dimer that uses a Ca 2+ -myristoyl switch mechanism to control binding and trafficking of α 4 β 2 nicotinic acetylcholine receptors as a possible mechanism for modulating neuronal excitability involved in synaptic plasticity and neurodegenerative diseases.
EXPERIMENTAL PROCEDURES
Preparation and Purification of Recombinant VILIPs. Human VILIP-1 and VILIP-3 genes were subcloned in pET3d(+) plasmids. The chimeric VILIPs were prepared by overlapping PCR reactions (34) . Site specific VILIP-1 mutants for disabling Ca 2+ binding (D73A (EF2∆), D109A(EF3∆), D159A(EF4∆)) or effecting dimerization (I136G/M137G, V151G and A174G)) were generated by QuikChange site-directed mutagenesis kit (Stratagene). Bacterial cells for expressing recombinant unmyristoylated VILIP proteins were generated by transforming BL21(DE3) cells with pET3d encoding the VILIP gene. Bacterial cells for expressing recombinant myristoylated VILIP proteins were generated by co-transforming BL21(DE3) cells with both pET3d-VILIP and pBB131 vector encoding yeast Nmyristoyltransferase(NMT).
The expression and purification of recombinant VILIPs has been described previously (34) . Briefly, bacterial cells harboring the VILIP-1 expression plasmid system above were grown in Luria-Bertani (LB) medium containing ampicilin (100 mg/L) at 37°C until the optical density (A 600 ) of the cell culture reached 1.0. The cells were diluted 1:50 in LB or M9 medium, incubated with shaking (250 rpm) at 37°C until A 600 reached 0.8.
Expression of recombinant unmyristoylated VILIP-1 protein was induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to the cell culture at a final concentration of 0.5mM and the cells were then grown at 25°C for 12-16 hr. Expression of recombinant myristoylated VILIPs followed a similar procedure except that kanamycin was added into the medium at a concentration of 50 mg/L to select for expression of NMT by pBB131-NMT. Myristic acid (10 mg/L) was added 1 hr before the induction by IPTG. For generating protein samples containing a 13 C-labeled myristoyl group, 13 C-labeled myristic acid (99% atom, Isotec) was used instead. The final bacterial cell pellet containing expressed VILIP protein was harvested by centrifugation. After centrifugation, the cell pellet was resuspended and sonicated in lysis buffer containing 20mM Tris (pH 7.5), 0.3M KCl, 1mM EDTA, 1mM DTT, 10% glycerol, 0.1M PMSF. The soluble proteins were recovered by ultracentrifugation. The supernatant was mixed with CaCl 2 to give a final Ca 2+ concentration of 4mM and then applied to butyl sepharose column (HiPrep 16/10 Butyl FF, Amersham) which was equilibrated with 20mM Tris (pH 7.5), 0.3M KCl, 2mM CaCl 2 ,1mM DTT. The column was washed with 6-10 column volumes of equilibration buffer, and then the VILIP-1 protein was eluted using a low Ca 2+ buffer (pH 7.5, 20mM Tris, 2mM EDTA, 1mM DTT) as described previously (30 Isothermal Titration Calorimetry. A VP-ITC calorimeter (Micro-Cal) was used for all ITC measurements, and the data were aquired and processed with MicroCal softwared as described previously (35) . VILIP-1 samples for ITC studies were first decalcified as described (36) Differential Scanning Calorimetry. A VP-DSC calorimeter from MicroCal was used for all DSC measurements, and the data were acquired and processed using MicroCal software as described previously (35) . Scanning was done in the temperature range of 10-110°C at a scan rate of 60°C/h. A buffer baseline was subtracted from each scan. Myristoylated and unmyristoylated VILIP-1 at concentrations of 50 µM were first decalcified as describe (36) and prepared in 20 mM Tris buffer (pH 7.5) containing 100 mM NaCl and 1 mM β-mercaptoethanol with or without 5 mM CaCl 2 The molar mass of VILIP-1 under these conditions was also verified using multi-angle light scattering (MALS) analysis as described previously (39) .
Homology Modeling and Docking Calculation. The three-dimensional structure of Ca 2+ free VILIP-1 was generated by homology modeling using the SWISS-MODEL workspace (40) (http://swissmodel.expasy.org/) based on the NMR structure of Ca 2+ -free myristoylated recoverin (1IKU). The structure of Ca 2+ -bound VILIP-1 was similarly generated using the crystal structure of Ca 2+ -bound neurocalcin (1BJF). The structure of the VILIP1 dimer was determined using the protein docking software, Haddock 2.0 (41,42) (http://haddock.chem.uu.nl/).
First, we experimentally identified essential residues for dimerization using the chimera analysis described below. The solvent accessibility of these residues was evaluated using the software, NACCESS (43) . VILIP-1 residues, 135-177 (derived from the chimera analysis) having >50% relative solvent accessibility were selected as Ambiguous Interaction Restraints (AIRs) (41) that were then used in the Haddock docking calculation to identify the structure of the dimerization interface. A cluster of 133 dimer structures was calculated with a Haddock score of -142.5 ± 7.1 and a root-mean-squared deviation of less than 1.5 Ǻ relative to the lowest energy structure. The van der Waals energy was -42.2 ± 2.1 kcal/mol with a desolvation energy of 4.1 ± 1.9 kcal/mol and restraints violation energy of 288.4 ± 45.39 kcal/mol. A Ramachandran analysis of the ensemble of structures (evaluated by the software, Procheck) revealed 83.5% of residues in the most favored regions, 15.2% in additional allowed regions, 0.6% in generously allowed regions, and only 0.6% in disallowed regions. Thus, the docking calculation of the VILIP-1 dimer appears to be well determined by the experimental restraints. To identify which particular EF-hands in VILIP-1 bind to Mg 2+ , we constructed 3 single-site mutants that disable divalent cation binding to the individual EF hands: D73A (EF2∆), D109A (EF3∆), D159A (EF4∆). The first EF-hand in all NCS proteins is known to be non-functional and was not mutated in this study. For each EF-hand mutant, a negatively charged Asp at the beginning of the EF-hand loop has been substituted with a neutral Ala residue. This substitution dramatically lowers the Ca 2+ and/or Mg 2+ binding affinity of the respective EF-hand outside of the physiological range (49) . As illustrated in Figure 2 and Table 1 (27) . Myristoylation of VILIP-1 dramatically affects the Ca 2+ -binding isotherms for VILIP-1, similar to the large effect of myristoylation on the Ca 2+ binding data for recoverin (28) and in contrast to that of GCAP-1 (39) . For unmyristoylated VILIP-1 (in the absence of Mg 2+ , Fig. 3A ), the ITC Ca 2+ binding isotherm exhibits two separate binding phases that could be fit by two independent sites. The highest affinity site is exothermic (∆H 1 = -9 kcal/mol and K 1 = 100 nM) followed by lower affinity endothermic binding (∆H 2 = +3.3 kcal/mol) in the micromolar range (K 2 = 1-4 µM). Similar independent and uncooperative Ca 2+ binding sites were observed previously for unmyristoylated forms of recoverin (28, 36) , chicken VILIP (27) , and neurocalcin δ (29).
RESULTS

Mg
The ITC Ca 2+ -binding isotherm for myristoylated VILIP-1 ( bind to VILIP-1 with positive cooperativity, which resembles the cooperative binding of 2 Ca 2+ to myristoylated recoverin (28) . The Ca 2+ binding data for VILIP-1 indicate that N-terminal myristoylation both lowers the apparent affinity (K D = 1.2 µM) and induces positive cooperativity (α = 1.5) like that observed for recoverin (28) and neurocalcin (29) , which is an important hallmark of a Ca 2+ -myristoyl switch.
The high resolution ITC data for both myristoylated and unmyristoylated VILIP-1 clearly indicated two separate binding sites having distinct values of ∆H and K D ; however it is difficult with the wildtype data alone to assign each of the binding phases as binding by a particular EF-hand. To identify which EF-hands bind to Ca 2+ , we performed ITC Ca 2+ titration on each of the EF-hand mutants (D73A(EF2∆), D109A(EF3∆), D159A(EF4∆)) (Fig. 3) . For unmyristoylated VILIP-1 (Fig.  3A) , the EF3∆ mutant lacks the high affinity Ca 2+ binding seen in the wildtype isotherm, and instead exhibits very low affinity binding of one Ca 2+ with a K D of ~100 µM, suggesting that EF3 may be the high affinity site. However, the NMR spectrum of the EF3∆ mutant suggests that this mutant protein may be partially misfolded, which might disable high affinity Ca 2+ binding and also explain the very low apparent affinity. The EF2∆ mutant, in contrast to EF3∆, is properly folded (based on its NMR spectrum) and exhibits high affinity binding of one Ca 2+ , while the lower affinity Ca 2+ -binding phase in the wildtype isotherm appears to be missing in this mutant, suggesting that EF2 must be the lower affinity site. The EF4∆ mutation had almost no affect on the Ca 2+ binding isotherm, indicating that VILIP-1 does not bind Ca 2+ at EF4 in the physiological range. By the process of elimination, EF3 must be the high affinity site, since EF2 is the low affinity site, and EF1 and EF4 do not bind Ca 2+ . For myristoylated VILIP-1 (Fig. 3B) , the EF3∆ mutant markedly impairs binding of both Ca 2+ , whereas the EF2∆ mutant abolishes Ca 2+ binding only at EF2 and retains high affinity binding of one Ca 2+ (K D = 3.9µM, ∆H = -4.5 kcal/mol). The lack of any Ca 2+ binding to myristoylated EF3∆ might again be the result of protein misfolding in this mutant as suggested by its NMR spectrum (see Supplementary Fig. S2 ). Alternatively, the lack of Ca 2+ binding to the EF3∆ mutant resembles the lack of binding seen previously for the EF3∆ mutant of recoverin which adopts a stable fold (50 Supplementary Fig. S4 ), the VILIP-1 protein has two intrinsically different binding sites for Ca 2+ and two global protein conformational states, T and R. The T state represents the protein conformation with a sequestered myristoyl group (see below) (32) and R represents the protein with an extruded myristoyl group (24) . Let K EF2 and K EF3 determined above for unmyristoylated VILIP-1 represent the dissociation constants of the two sites in the R state as justified previously (28 (24, 33) . The transition peaks in all the DSC thermograms did not fully reappear upon re-scanning each of the samples, suggesting irreversible unfolding due to aggregation and/or denaturation. However, the pre-transitional baseline and T m in each case were independent of protein concentration and scan-rate, consistent with a two-state model of unfolding.
Unfortunately, the DSC thermograms of apo, Mg 2+ -bound, and Ca 2+ -bound VILIP-1 were all quite broad with steeply sloped post-transitional baselines, making it difficult to quantitatively fit these thermograms by a two-state model. The steep and highly curved baseline is most likely due to protein aggregation that may have occurred during unfolding at the very high melting temperatures.
NMR Structural Analysis of VILIP-1. NMR spectroscopy was used to probe atomiclevel protein conformational changes in VILIP-1 induced by Mg 2+ and/or Ca 2+ binding (Figure 4) . The peaks in the 1 H-15 N HSQC NMR spectra represent main-chain and sidechain amide groups and provide a fingerprint of the overall protein conformation. The spectrum of Ca 2+ -free myristoylated VILIP-1 (Fig. 4A) is somewhat similar to that of Mg 2+ -bound myristoylated protein (Fig. 4B) Supplementary Fig. S1 . These NMR assignments indicate that the chemical shifts and NOE patterns for conserved residues in VILIP-1 (L16, T20, W30, Y31, F34, L36,  C39, S40, G41, Y52, F55, F56, D60, A88,  L89, T92, S93, W103, A104, Y108, G112,  G114, I116, I124, I128, T147, T167, E170,  F171 ) are all very similar to those of Ca 2+ -free myristoylated recoverin. Thus, the structures of recoverin and VILIP-1 in the Ca 2+ -free state must be very similar, which validates the homology modeled structure of Ca 2+ -free myristoylated VILIP-1 discussed below.
The addition of saturating Ca 2+ to myristoylated VILIP-1 causes the HSQC spectrum to change quite significantly (Fig.  4C) Figure 5 , the 13 C-1 H HMQC experiment selectively probes protons that are covalently attached to 13 C so that only the methylene and methyl resonances of the myristoyl group appear in the spectra. The HMQC spectrum of the 13 (24, 33) .
To further test whether VILIP-1 has a sequestered myristoyl group in the Ca 2+ -free state, two-dimensional ( 13 C/F1)-edited and ( 13 C/F2)-filtered NOESY experiments were performed on Ca 2+ -free/Mg 2+ -bound VILIP-1 (unlabeled) containing a 13 C-labeled myristate. This NOESY spectrum exhibits nuclear Overhauser effect cross-peaks between the fatty acyl group and many protein resonances particularly from aromatic residues (Figure. 5C). The NMR chemical shifts and NOE patterns in Fig. 5C are similar to those of Ca 2+ -free recoverin (32) . In VILIP-1, the strongest NOESY crosspeaks involve the C 14 methyl resonance of the myristoyl group that forms hydrophobic contacts with protein aromatic resonances (F49, Y52, F55, and F85) and other hydrophobic residues inside the hydrophobic core of the protein. The large intensity of these NOESY crosspeaks indicates that the C 14 methyl group of the myristate chain must be located less than 5 angstroms away from hydrophobic side-chain atoms inside the protein hydrophobic core. These proteinmyristate contacts imply that the covalently attached fatty acyl group must be sequestered inside the Ca 2+ -free VILIP-1 protein similar to the sequestered myristoyl group inside Ca 2+ -free recoverin (32, 33) .
VILIP-1 Dimerization. Previous studies have shown that VILIP-1 forms an equilibrium mixture of monomeric and dimeric protein species (34) . In our current study, we use size exclusion chromatography (SEC), NMR spectroscopy, and chimera analysis to characterize the dimeric structure and understand the effect of Mg 2+ , Ca 2+ and myristoylation (Fig. 6) (Fig. 6) . The relative intensities of the SEC elution bands suggest a 2:1 equilibrium ratio of VILIP-1 monomer to dimer at 1 µM total protein concentration. The dissociation constant for the VILIP-1 dimerization was estimated based on SEC data to be 1-10 µM. The amount of dimerization was not affected by adding excess reducing agent (i.e. 10 mM dithiothreitol or TCEP). Thus, the VILIP-1 dimer is not caused by cysteine oxidation, in contrast to suggestions by (34) . Nearly identical dimerization properties were observed for unmyristoylated VILIP-1 (not shown). The dimerization of unmyristoylated VILIP-1 is independent of both Ca 2+ and Mg 2+ . Thus, the dimerization of VILIP-1 in this study does NOT involve cysteine oxidation and is independent of Mg 2+ , Ca 2+ and myristoylation (not counting the artificial aggregation of Ca 2+ -saturated myristoylated VILIP-1). Under the same conditions, our SEC studies show that recoverin and VILIP-3 are both monomeric regardless of Mg 2+ , Ca 2+ or myristoylation. Dimerization of VILIP-1 was shown previously to be disrupted by swapping its entire C-terminal domain with that of VILIP-3, implying that the dimerization site in VILIP-1 must be localized in the C-terminal half of VILIP-1 (34) . To more precisely localize the dimerization interface of VILIP1, we made three distinct chimeric constructs between VILIP-1 and VILIP-3: V13A (VILIP-1 residues, 1-177aa and VILIP-3 residues, 178-193), V13B (VILIP-1 residues, 1-148 and VILIP-3 residues, 149-193), and V13C (VILIP-1 residues, 1-132 and VILIP-3 residues, 133-193). The SEC analysis on each of the chimeras is shown in Fig. 6 . The SEC analysis on V13C indicates that this protein is 100% monomeric, demonstrating that VILIP-1 residues in the loop region between EF3 and EF4 and residues in EF4 are essential for protein dimerization. The SEC analysis on V13B indicates that the amount of protein dimerization was decreased by ~2-fold, consistent with VILIP-1 residues in EF4 being important for dimerization. The chimera V13A shows the same amount of dimerization as that of wildtype, indicating that C-terminal residues (178-191) after EF4 in VILIP-1 are not important for dimerization. Thus, the SEC results demonstrate that residues in EF1, EF2 and EF3 (residues 1-132) are NOT necessary for VILIP-1 dimerization, and that the nonconserved residues in the loop region between EF3 and EF4 and exposed residues in EF4 represent the minimal number of residues in VILIP-1 that are necessary and sufficient for dimerization. Indeed, mutants of the nonconserved residues in these regions (I136G/M137G, V151G and A174G) all weaken the dimerization affinity but remain structurally intact as judged by NMR. The most striking effect is seen by the double mutant, I136G/M137G that lowers the dimerization affinity by ~10-fold (highlighted purple in Fig. 6 ).
Structural Model of VILIP-1 Dimer. The structure of VILIP-1 dimer was generated by homology modeling and protein docking calculations. The first step was to determine the three-dimensional structures of monomeric forms of Ca 2+ -free and Ca 2+ -bound VILIP-1 using homology modeling (see Methods). Human VILIP-1 shares 54% sequence identity with bovine recoverin and 58% identity with bovine neurocalcin, implying that the mainchain structure of VILIP-1 should be very similar to those of recoverin and neurocalin. Indeed, the NMR backbone assignments of Mg 2+ -bound/Ca 2+ -free VILIP-1 ( Supplementary Fig. S1 ) indicate that the chemical shifts and NOE patterns for conserved residues in VILIP-1 (L16, T20,  W30, Y31, F34, L36, C39, S40, G41, Y52,  F55, F56, D60, A88, L89, T92, S93, W103,  A104, Y108, G112, G114, I116, I124, I128,  T147 , T167, E170, F171) are all very similar to those of Ca 2+ -free myristoylated recoverin. In addition, the NMR chemical shifts and NOE patterns of the myristoyl group interaction with VILIP-1 (Fig. 5) and NOE patterns of distinct Leu and Val methyl resonances in the VILIP-1 hydrophobic core are quite similar to those observed for Ca 2+ -free recoverin (24, 32) . Therefore, the structure of Ca 2+ -free VILIP-1 must be very similar to that of recoverin and was modeled on the basis of the NMR structure of Ca 2+ -free myristoylated recoverin (1IKU). The homology modeled structure of Ca 2+ -free VILIP-1 (Fig. 7A) shows the Nterminal myristoyl group sequestered inside the protein hydrophobic core, consistent with the NMR spectra of the myristoyl group (Fig.  5) . VILIP-1 residues, L27, W30, F48, L51, Y52, F55, F82, F85, L89, W103 and M107 make important hydrophobic contacts with the N-terminal myristoyl group as verified by the NMR assignments and spectrum in Fig. 5C .
The structure of Ca 2+ -bound VILIP-1 (Fig. 7B) was modeled on the basis of the crystal structure of Ca 2+ -bound neurocalcin (1BJF), which is the closest available structure of a Ca 2+ -bound NCS protein dimer that has highest sequence identity to VILIP-1. Ca 2+ -bound neurocalcin forms a dimer in solution (54) , and the crystal structure of the Ca 2+ -bound dimer (26) specifies intermolecular contacts primarily between residues in the Nterminal domain (EF1 and EF2) and exposed residues in EF3. Our chimera analysis above on VILIP-1 precludes any intermolecular dimer contacts involving residues in EF1, EF2 and EF3 (i.e. between the two domains), and therefore the dimeric structure of VILIP-1 must be different from that of neurocalcin.
To generate a structure of the VILIP-1 dimer consistent with the chimera data above, we used a protein docking approach (see Methods) applied to the structure of Ca 2+ -bound VILIP-1 in Fig. 7B . The docking calculation (see Methods) was performed using constraints from the chimera analysis above. The docking results reveal a cluster of 133 lowest energy dimeric structures that are all consistent with the chimera data, and the lowest energy structure is shown in Fig. 8 . The VILIP-1 dimer adopts an elongated structure (48 x 22 x 18 Ǻ) in which the two monomeric subunits are attached to one another at their exposed C-terminal ends. At the dimer interface, the exposed helices of EF4 are packed against each other in a face-to-face fashion, forming an interfacial structure that resembles a four helix bundle. The exposed residues on the EF4 entering helix (V151, I154 and F155) make close contacts with exposed residues on the EF4 exiting helix in the opposite chain (F171, A174 and A175) and vice versa. The loop region between EF3 and EF4 contact each other at the dimer interface, forming multiple hydrophobic contacts involving I136, M137, M138 and M140. Thus, the dimer interface is mostly hydrophobic formed by contacts from non-conserved and exposed residues, I136, M137, M138, M140, V151, I154, F155, F171, A174, and A175 (highlighted red in Figs. 1 and 8A ). The importance of these residues for dimerization is demonstrated by mutants (I136G/M137G, V151G and A174G) that all weaken the dimerization affinity (Fig. 6) . The VILIP-1 dimer structure has the N-terminal myristoyl group from each polypeptide chain pointing upward in the same direction to serve as a dual-pronged anchor for targeting VILIP-1 to membranes (Fig. 9) . The opposite surface of the VILIP-1 dimer (highlighted yellow in Fig.  8B ) contains an exposed hydrophobic crevice from each monomeric subunit (lined by residues F22, W30, L43, F48, I51, Y52, F55, F56, F72, F82, F85, I86, A88, L89) that we suggest may interact with hydrophobic segments of target proteins.
DISCUSSION
In (24, 33) . However, unlike recoverin, VILIP-1 forms a stable protein dimer that is independent of Ca 2+ , Mg 2+ or myristoylation. The dimerization site is composed of non-conserved residues between EF3 and EF4 and exposed residues in EF4. Indeed, mutation of the non-conserved residues between EF3 and EF4 (I136G/M137G) dramatically weakens the dimerization affinity (Fig. 6) . The structure of the VILIP-1 dimer reveals that the N-terminal myristoyl group, attached at opposite ends of the dimer provides a double-pronged anchor for insertion into membranes (Fig. 8A ). The exposed cytosolic surface of the membranebound VILIP-1 dimer contains two separate hydrophobic patches (Fig. 8B ) that may interact with target proteins.
Implications of VILIP-1 Dimerization and the Ca
2+ -myristoyl Switch. VILIP-1 has been shown previously to facilitate the Ca 2+ -induced trafficking of the alpha4-subunit (α 4 ) of nicotinic acetylcholine receptors (nAChR) (14) . The Ca 2+ -dependent conformational changes and dimeric structure of VILIP-1 determined in this study suggest a molecular mechanism for Ca 2+ -induced trafficking of nAChRs (Fig. 9) . We propose that the exposed hydrophobic crevice on the surface of Ca 2+ -bound VILIP-1 dimer (highlighted yellow in Fig. 8B ) may serve as a target binding site like that observed previously in the structures of recoverin bound to rhodopsin kinase (56) and yeast frequenin bound to PtdIns 4-kinase (57 (Fig. 8A ) with concomitant exposure of two separate hydrophobic crevices (highlighted yellow in Fig. 8B ). The Ca 2+ -bound VILIP-1 dimer is then poised to interact with two molecules of the nAChR α 4 -subunit (α 4 ) that initially reside in the ER, and upon appropriate stimulation, traffic via Golgi vesicles to the cell surface (14) . We propose that the translocation of α 4 from the ER via Golgi to the plasma membrane is enhanced by VILIP-1 via the Ca 2+ -myristoyl switch mechanism. It is conceivable that the binding of VILIP-1 to two α 4 subunits in the nascent receptor complex favors the assembly and/or trafficking of the high affinity α 4 β 2 nAChR, containing two rather than three α 4 -subunits (58) , to the plasma membrane. This process leads to VILIP-1-dependent accumulation of high affinity α 4 β 2 nAChR at the cell membrane surface (14) . In short, this mechanism might explain how VILIP-1 dimerization and a Ca 2+ -myristoyl switch mechanism are combined structurally to promote VILIP-1-dependent trafficking of nAChRs (13, 14) . As a functional result, the nAChR channel activity becomes upregulated by VILIP-1 that ultimately leads to increased neuronal excitability, implicated in synaptic plasticity and neuronal diseases (16, 17) . To more rigorously test this mechanism in the future, we plan to determine the structure of the VILIP-1 dimer bound to functional fragments of α 4 β 2 nAChR using NMR and/or x-ray crystallography. 
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